Previous 10 | Next 10 |
2023-08-25 05:10:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) and 23andMe (NASDAQ: ME) are both popular biotech stocks that are wooing investors with their claims about using artificial intelligence (AI) to supercharge the drug development process. But over the last three ...
2023-08-11 09:53:00 ET When it comes to complex biotech stocks like Recursion Pharmaceuticals (NASDAQ: RXRX) , skilled investors are likely to have an outsized advantage in understanding how the future will play out. Whether it's a matter of how to judge developments like new collab...
2023-08-08 09:04:23 ET Recursion Pharmaceuticals press release ( NASDAQ: RXRX ): Q2 GAAP EPS of -$0.38. Revenue of $11M (+42.9% Y/Y). For further details see: Recursion Pharmaceuticals GAAP EPS of -$0.38, revenue of $11M
SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has successfully screened the Enamine REAL Space chemical library using its MatchMaker technology, recently a...
Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein interactions for approximately 36 billion compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library Added, accelerated or tightened guidance for cl...
2023-08-02 07:45:00 ET The cost and high failure rate related to bringing drugs and medical devices to market opens healthcare to more artificial intelligence (AI)-connected disruption than perhaps any other industry. A lot of healthcare companies are seeking to brandish their AI bo...
2023-07-31 12:56:01 ET Summary The bulls and bears are divided over the future trajectory for Nvidia Corporation stock after the massive jump in 2023. The estimated total addressable market size in AI varies according to analysts, but we can say with a very high degree of certaint...
SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today launched Valence Labs at the International Conference on Machine Learning (ICML). Valence Labs will serve as a machi...
2023-07-21 10:07:00 ET Artificial intelligence (AI) is all the rage these days, even in fields like biotech, where long product development cycles mean that cool new tools today might not lead to cash flows for years. In particular, there is a trio of biotechs going all-in on AI, and so far...
2023-07-19 06:30:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As you’re surely aware, Nvidia (NASDAQ: NVDA ) stock has moved relentlessly higher this year so far. This is probably due to the market’s hype over artificial intellig...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...